300485 Stock Overview
A biopharmaceutical company, engages in the research and development, production, and sales of injections in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Beijing Science Sun Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.13 |
| 52 Week High | CN¥9.45 |
| 52 Week Low | CN¥5.73 |
| Beta | 0.032 |
| 1 Month Change | 4.39% |
| 3 Month Change | -10.88% |
| 1 Year Change | -10.65% |
| 3 Year Change | -52.12% |
| 5 Year Change | -28.63% |
| Change since IPO | -69.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300485 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 0.1% | 1.2% | -0.08% |
| 1Y | -10.7% | -10.4% | 17.3% |
Return vs Industry: 300485 matched the CN Biotechs industry which returned -10.4% over the past year.
Return vs Market: 300485 underperformed the CN Market which returned 17.3% over the past year.
Price Volatility
| 300485 volatility | |
|---|---|
| 300485 Average Weekly Movement | 4.1% |
| Biotechs Industry Average Movement | 5.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in CN Market | 10.5% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 300485 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300485's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 532 | Biao Ma | www.ssyy.com.cn |
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sales of injections in China. It offers products for cardiovascular, cerebrovascular, immunomodulation, nervous systems, and other varieties. The company is also engaged in the research, development, production, and sale of raw materials; extraction of traditional Chinese medicine; and the manufacture of Chinese and Western medicine preparations.
Beijing Science Sun Pharmaceutical Co., Ltd. Fundamentals Summary
| 300485 fundamental statistics | |
|---|---|
| Market cap | CN¥3.43b |
| Earnings (TTM) | -CN¥191.81m |
| Revenue (TTM) | CN¥405.63m |
8.5x
P/S Ratio-17.9x
P/E RatioIs 300485 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300485 income statement (TTM) | |
|---|---|
| Revenue | CN¥405.63m |
| Cost of Revenue | CN¥138.45m |
| Gross Profit | CN¥267.17m |
| Other Expenses | CN¥458.98m |
| Earnings | -CN¥191.81m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 29, 2025
| Earnings per share (EPS) | -0.40 |
| Gross Margin | 65.87% |
| Net Profit Margin | -47.29% |
| Debt/Equity Ratio | 0% |
How did 300485 perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield-6%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/19 22:57 |
| End of Day Share Price | 2025/02/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beijing Science Sun Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Hui Tang | Chasing Securities |